Immune checkpoint inhibitors ikirasi yemishonga inorwisa immune system yemuviri kurwisa cancer maseru. Zvisinei, varwere vakawanda havapinduri kune idzi marapirwo. Pane kirasi itsva yemushonga inonangana mapuroteni maviri ane chekuita nekudzvanyirira kudzivirira kwemuviri kubva kumamota.
Phase I of clinical trials has shown some exciting results, which were conducted in 19 patients suffering from kenza with the molecule M7824. These researchers are also undertaking trials with those suffering from pancreatic cancer and those infected with HPV.
There are many other trials and experiments being taken to treat and kurapa cancer more effectively in different research institutes. This drug with a dual approach will be a boon in the kurapwa kenza, as with a single molecule, multiple therapies are included.
